Pyxis Oncology is trading 5.5% up today at $3.07, extending a sharp rebound following a brief pullback and last week's multi-session rally.
- The stock's recent strength includes double-digit percentage gains recorded on July 22 and July 27.
- The current move appears to be driven by ongoing technical momentum rather than any new company-specific catalysts or fresh fundamental news.